Vorrichtung zur Extrakorporalen Blutbehandlung
Anmelder: Gambro Lundia AB 🇸🇪
Details
- Veröffentlichungs-Nr.
- EP4098291
- Aktenzeichen
- EP21176784
- Anmeldetag
- 31. Mai 2021
- Veröffentlichung
- 21. Januar 2026
- Erteilung
- 21. Januar 2026
- Rechtsraum
- EP
- IPC
- A61M1/16A61M1/36
Abstract
A control unit of an apparatus for extracorporeal blood treatment is configured to perform a control procedure comprising: calculating parameter control values to be set during a time interval after the instant in which the control is made, on the basis of actual values and of prescription values of variation in blood volume, ultrafiltration flow rate, concentration of sodium; imposing the parameter control values during the time interval consecutive to the instant in which the control is made such that the actual values of the variation in blood volume track the prescription values of the variation in blood volume over a predetermined treatment time. The control unit is further configured to perform a procedure for automatically estimating/calculating a target plasma conductivity and/or a target concentration of sodium in plasma to be reached at the end of the extracorporeal blood treatment.
Anmelder
- Firma
- Gambro Lundia AB
- Land
- 🇸🇪 Schweden
Schwedisches Unternehmen, das medizintechnische Geräte und Verbrauchsmaterialien für Dialyse und Blutbehandlung entwickelt, heute Teil von Baxter.
816 Patente in unserer Datenbank